Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$774M |
| 2 |
Intuitive Surgical
ISRG
|
+$654M |
| 3 |
S&P Global
SPGI
|
+$464M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$326M |
| 5 |
CELG
Celgene Corp
CELG
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$591M |
| 2 |
Broadcom
AVGO
|
+$550M |
| 3 |
Monster Beverage
MNST
|
+$408M |
| 4 |
Booking.com
BKNG
|
+$377M |
| 5 |
McDonald's
MCD
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.49% |
| 2 | Consumer Discretionary | 16.46% |
| 3 | Healthcare | 15.81% |
| 4 | Financials | 12.97% |
| 5 | Communication Services | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Kennametal
KMT
$2.25B
| – | – |
-13,619
| Closed | -$489K |
|
677
Standard BioTools
LAB
$252M
| – | – |
-68,791
| Closed | -$410K |
|
678
Littelfuse
LFUS
$10.3B
| – | – |
-31,376
| Closed | -$7.16M |
|
679
Match Group
MTCH
$9.54B
| – | – |
-15,740
| Closed | -$610K |
|
|
NAK
680
Northern Dynasty Minerals
NAK
$944M
| – | – |
-1,763,422
| Closed | -$955K |
|
681
Nutanix
NTNX
$18.7B
| – | – |
-11,872
| Closed | -$612K |
|
682
Nu Skin
NUS
$236M
| – | – |
-21,862
| Closed | -$1.71M |
|
683
OceanFirst Financial
OCFC
$1.82B
| – | – |
-37,293
| Closed | -$1.12M |
|
684
ON Semiconductor
ON
$28.3B
| – | – |
-29,611
| Closed | -$658K |
|
685
Oracle
ORCL
$435B
| – | – |
-458,347
| Closed | -$20.2M |
|
686
Ovid Therapeutics
OVID
$547M
| – | – |
-394,436
| Closed | -$3.08M |
|
687
Provident Financial Services
PFS
$3.07B
| – | – |
-60,246
| Closed | -$1.66M |
|
688
Pinnacle West Capital
PNW
$11.8B
| – | – |
-580,669
| Closed | -$46.8M |
|
689
Power Integrations
POWI
$2.88B
| – | – |
-9,466
| Closed | -$346K |
|
690
Royal Caribbean
RCL
$74.7B
| – | – |
-296,585
| Closed | -$30.7M |
|
|
REVG
691
DELISTED
REV Group
REVG
| – | – |
-509,537
| Closed | -$8.67M |
|
692
RLI Corp
RLI
$5.9B
| – | – |
-8,732
| Closed | -$289K |
|
693
Sally Beauty Holdings
SBH
$1.55B
| – | – |
-41,979
| Closed | -$673K |
|
694
Starbucks
SBUX
$123B
| – | – |
-107,612
| Closed | -$5.26M |
|
|
SEE
695
DELISTED
Sealed Air
SEE
| – | – |
-2,401,902
| Closed | -$102M |
|
696
Silicon Laboratories
SLAB
$7.29B
| – | – |
-15,529
| Closed | -$1.55M |
|
697
Semtech
SMTC
$12.2B
| – | – |
-13,812
| Closed | -$650K |
|
698
Schneider National
SNDR
$6.04B
| – | – |
-593,261
| Closed | -$16.3M |
|
699
Supernus Pharmaceuticals
SUPN
$2.54B
| – | – |
-9,837
| Closed | -$589K |
|
700
Savara
SVRA
$1.08B
| – | – |
-794,234
| Closed | -$8.99M |
|
Similar funds
Jennison Associates's Q3 2018 Portfolio in Review
As of Q3 2018, Jennison Associates held 739 positions worth $109B, up 5.9% from $103B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q3 2018 filing shows 86 new, 214 increased, 352 reduced and 81 closed positions. Its largest new stake was Tiffany & Co.: 1,169,094 shares worth $151M. The largest sale was FedEx, an estimated $591M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2018 buy was Tiffany & Co.: 1,169,094 shares worth $151M.
- Jennison Associates added most to AstraZeneca in Q3 2018, an estimated $774M increase.
- Jennison Associates's biggest Q3 2018 reduction was FedEx, cutting an estimated $591M.
- Jennison Associates fully exited Cheniere Energy Partners LP Holdings LLC in Q3 2018, selling an estimated $134M.
- Jennison Associates's ten largest holdings make up 30% of its $109B portfolio in Q3 2018.
- Jennison Associates opened 86 new positions and closed 81 in Q3 2018.
- Jennison Associates's portfolio value rose 5.9% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q3 2018, filed 8 Nov 2018.